Japanese Firms Advance Share Buybacks in June; Koito Delays Initial Purchases

Koito Manufacturing’s June buyback update indicates purchases will be conducted on the market on the Tokyo Stock Exchange, including the ToSTNeT-3 off-auction system, under a framework that extends through May 31, 2027 (no buys in June yet).
Mochida Pharmaceutical’s buyback is being executed through discretionary dealing contracts, giving management flexibility to pace purchases, with not all of the planned 530,000 shares likely to be completed.
Komatsu Ltd.’s program appears to have board authorization in April (earlier than some reports) and has already repurchased about 2 million shares in June 2026 as part of a plan targeting up to 25 million shares or ¥100 billion by September 2026.
DaikyoNishikawa’s governance detail shows leadership involvement in the buyback: Representative Director and President Ikuo Sugiyama oversees execution, with Managing Executive Officer Katsumi Yamada handling corporate planning.
Koito Manufacturing approved one of Japan's largest buyback programs — up to 25 million shares or 50 billion yen — but purchased zero shares in June 2026, according to MarketScreener. The company has a window stretching through May 31, 2027, leaving ample time to act, but the slow start drew attention as peers moved quickly.
Across five Japanese companies reporting June buyback activity, the contrast was sharp. Komatsu repurchased roughly 2 million shares in June alone, while smaller firms like DaikyoNishikawa and Mochida Pharmaceutical kept steady paces. Analysts, however, remain skeptical — rating Koito and Sumitomo Warehouse as Sell, and Komatsu only as Hold.
Koito's board approved the buyback in May 2026. The plan allows purchases on the Tokyo Stock Exchange, including the ToSTNeT-3 off-auction system — a tool used for large block trades away from the open market. Despite the open window, MarketScreener confirmed zero shares were bought in June.
Analysts suggest the delay may be tactical. Koito could be waiting for the stock to fall closer to its 2,400 yen Sell target before buying. A ToSTNeT-3 transaction would also let the company retire a large block in a single day without pushing the price up. Either way, the clock is running — Koito has until May 31, 2027.
Komatsu's board authorized its program in April 2026, setting a ceiling of 25 million shares or 100 billion yen through September 2026. By the end of June, the company had repurchased 9.59 million shares — nearly 40% of its limit — spending about 61.71 billion yen, according to MarketScreener.
Despite the aggressive pace, analysts rate Komatsu as Hold with a 5,900 yen target. Concerns about weak Chinese construction demand continue to weigh on the stock. The buyback boosts earnings per share, but it does not fix the demand problem.
DaikyoNishikawa bought 516,200 shares in June, bringing its total to 804,500 shares for about 830 million yen. Its program allows up to 2.85 million shares or 2 billion yen through late September. President Ikuo Sugiyama oversees execution, with Managing Executive Officer Katsumi Yamada handling corporate planning, per MarketScreener.
Mochida Pharmaceutical added 60,600 shares in June for roughly 192.8 million yen, bringing its running total to 95,900 shares and 317.2 million yen. The program uses a discretionary dealing contract — a setup where a securities firm paces purchases without daily instructions from Mochida. That flexibility has so far meant a slow pace against a ceiling of 530,000 shares and 2 billion yen.
Sumitomo Warehouse repurchased 181,600 shares in June, lifting its cumulative total to 360,300 shares and about 1.4 billion yen, according to MarketScreener. Its program permits up to 2 million shares or 7 billion yen through March 24, 2027 — so it has spent roughly 20% of its budget so far.
Like Koito, Sumitomo Warehouse carries a Sell rating — with a target of 3,000 yen. Critics see the buyback as a short-term floor for the stock price rather than a sign of real growth. The Tokyo Stock Exchange's 2023 pressure on companies to improve returns has pushed many firms to buy back shares, but analysts say that alone will not change weak fundamentals.
Publishers
15
Articles
27
Reach
42